Director Johnson Mercedes sold 625 shares of TERADYNE, INC (NASDAQ:TER) common stock on April 6, 2026, at $312.20 per share, producing a gross transaction value of $195,125. At the time of the sale, Teradyne shares were trading around $313.35, following a one-year appreciation of approximately 334%.
After the disposal, Mercedes continues to hold a direct position of 6,363 shares in the company. In addition to that direct stake, Mercedes maintains an indirect interest of 1,876 shares via The Mercedes Johnson Trust UAD 07/23/04, in which Mercedes serves as both trustee and sole beneficiary.
The sale was carried out under a pre-established sales arrangement that Mercedes adopted on February 3, 2025. That plan was structured to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, which permits insiders to set up automated trading plans to avoid questions about trading on material nonpublic information.
Market context and corporate developments
Teradyne, a semiconductor testing equipment manufacturer with a market capitalization reported at $49 billion, has recently signaled strategic shifts and product introductions. The company rolled out two new testing platforms: the Photon 100, an automated test system intended for silicon photonics and co-packaged optics manufacturing with design focus on high-volume production; and Omnyx, a platform aimed at testing printed circuit board assemblies for AI and data center workloads, which combines several testing capabilities into a single system.
Those product moves coincide with notable analyst attention. Cantor Fitzgerald raised its price target on Teradyne to $330 while maintaining an Overweight rating. The firm tied its outlook in part to Teradyne’s increasing exposure to artificial intelligence-related demand, which the company reported accounted for over 60% of total revenues in the fourth quarter of 2025. Morgan Stanley also lifted its price target to $306, citing stronger networking growth trends. Aletheia noted a rebound in Taiwan’s tester imports in February, attributing the recovery to large orders.
Independent valuation analysis from InvestingPro is cited as indicating that Teradyne currently appears overvalued. That service also provides Fair Value estimates and lists 17 additional ProTips for investors evaluating TER, and features Teradyne in a Pro Research Report among coverage of more than 1,400 U.S. equities.
Summary
Johnson Mercedes’ sale of 625 Teradyne shares on April 6, 2026, was executed under a Rule 10b5-1 plan adopted in February 2025. Mercedes retains both direct and indirect holdings following the trade. The disposal occurred while Teradyne shares trade near $313.35 after a large 12-month increase, and as the company introduces new testing platforms and receives higher price targets from several analysts.
Key points
- Insider transaction: Director Johnson Mercedes sold 625 shares for $312.20 each on April 6, 2026, totaling $195,125.
- Post-sale holdings: Mercedes now directly owns 6,363 shares and indirectly owns 1,876 shares through a trust where Mercedes is trustee and sole beneficiary.
- Company developments: Teradyne launched Photon 100 and Omnyx testing platforms and saw analysts raise price targets amid a shift toward AI-related revenue, which exceeded 60% of Q4 2025 sales.
Risks and uncertainties
- Valuation concern - InvestingPro analysis indicates the company appears overvalued, which could affect investor expectations in the semiconductor equipment sector.
- Market dependence - A substantial portion of recent revenue is tied to AI-related demand; fluctuations in AI or data center spending could influence Teradyne’s sales trajectory and the broader testing equipment market.
- Order and regional variability - Rebounds in regional imports, such as Taiwan’s tester imports in February, may be subject to large order timing and could introduce variability to short-term demand for testing equipment.
These facts outline a period of strong share-price performance and active corporate development for Teradyne, set against questions about valuation and concentration of revenue sources. The director sale was processed via an established 10b5-1 plan and did not change Mercedes’ remaining direct or indirect holdings as detailed above.